期刊文献+

基于CGGA数据库的325例脑胶质瘤患者PSMB8表达水平与临床特征的相关性研究 被引量:5

Correlation of PSMB8 expression and clinical characterization in 325 brain glioma patients based on CGGA database
下载PDF
导出
摘要 利用CGGA数据库,采集325例胶质瘤患者基因表达和临床信息,探讨蛋白酶体亚单位β-8(PSMB8)mRNA表达水平与胶质瘤患者临床特征及预后的关系。结果显示PSMB8 mRNA在高级别胶质瘤患者和异柠檬酸脱氢酶1野生型(IDH1-wt)患者中高表达。Pearson相关分析显示PSMB8与其他PSMB基因相关,表明PSMB8 mRNA表达与胶质瘤的恶性表型呈正相关,与总生存期(OS)呈负相关。推测抑制PSMB8可作为治疗PSMB8高表达胶质瘤的一种新方案。 To investigate the relationship between proteasome 20S subunit beta 8(PSMB8)mRNA expression and clinical characteristics and prognosis of glioma patients.325 patients with gliomas were from CGGA.PSMB8 mRNA was enriched in high-grade glioma and isocitrate dehydrogenase 1 wild-type(IDH1-wt)group.Pearson correlation test showed that PSMB8 was correlated with other PSMB8 genes.PSMB8 mRNA expression was positively correlated with malignant phenotype and negatively correlated with overall survival(OS),suppression of PSMB8 may be taken as a new strategy for the treatment of PSMB8 over expressing gliomas.
作者 龙腾飞 张红雁 吴爱林 高劲 刘鹤飞 柳璐 张琦 Long Tengfei;Zhang Hongyan;Wu AiLin(Dept of Tumor Radiotherapy,Hefei Ion Medical Center,The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei 230088;Dept of Tumor Radiotherapy,The First Affiliated Hospital of University of Science and Technology of China West District(Anhui Provincial Cancer Hospital),Hefei 230031)
出处 《安徽医科大学学报》 CAS 北大核心 2021年第11期1833-1837,共5页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金(编号:11805198)。
关键词 蛋白酶体亚单位β-8基因 胶质瘤 免疫治疗 PSMB8 gene glioma immunotherapy
  • 相关文献

参考文献1

二级参考文献105

  • 1Coley WB. II. Contribution to the knowledge of sarcoma. Ann Surg, 1891,14: 199-220.
  • 2Clauberg KW. The immunobiological legacy of Emil von Behring and Paul Ehrlich. Dtsch Med J, 1954,5:138-146.[in undetermined language].
  • 3Burnet M. Cancer; a biological approach. I. The processes of control. Br Med J, 1957,1 :779-786.
  • 4Thomas L, Lawrence HS. Cellular and humoral aspects of the hypersensitive states. New York: Hoeber-Harper, 1959:529-532.
  • 5Knuth A, Wolfel T, Klehmann E, et al. Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection. Proc Natl Acad Sci USA, 1989,86:2804-2808.
  • 6Parker GA, Rosenberg SA. Serologic identification of multiple tumor-associated antigens on murine sarcomas. J Natl Cancer Inst, 1977,58:1303-1309.
  • 7Cheever MA, Allison JP, Ferris AS, et al. The prioritization of cancer antigens: a National Cancer Institute pilot project for the acceleration of translational research. Clin Cancer Res, 2009,15:5323-5337.
  • 8Nukaya I, Yasumoto M, Iwasaki T, et al. Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor?reactive cytotoxic T lymphocyte. Int J Cancer, 1999,80:92-97.
  • 9Rosenberg SA, Kawakami Y, Robbins PF, et al. Identification of the genes encoding cancer antigens: implications for cancer immunotherapy. Adv Cancer Res, 1996,70: 145-177.
  • 10Wayteck L; Breckpot K, Demeester J, et al. A personalized view on cancer immunotherapy. Cancer Lett, 2014,352: 113-125.

共引文献15

同被引文献47

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部